Clinical Commissioning Policies

Overview

We are consulting on 4 new documents:

• Bortezomib for the Treatment of Refractory Antibody Mediated Rejection Post Kidney Transplant- Internal Medicine
• Eculizamab for the Treatment of Refractory Antibody Mediated Rejection Post Kidney Transplant- Internal Medicine
• Non Invasively Lengthened Spinal Rods for Scoliosis- Trauma
• Dolutegravir for the Treatment of HIV- 1 in Adults and Adolescents- Cancer and Blood

Consultation will be open until 17 September 2014.

If you have any queries about the consultation, please contact Julie Cunningham at julie.cunningham2@nhs.net